L-Arginine(CAS No.74-79-3) is a naturally occurring amino acid, often referred to as a semi-essential amino acid because the body can produce it, but under certain conditions, supplementation may be necessary. It plays a crucial role in various physiological processes and is commonly used as a dietary supplement to support overall health and wellness.
As a precursor to nitric oxide (NO) synthesis, L-Arginine is particularly known for its ability to promote blood vessel dilation and improve blood flow. This effect can have several potential benefits, such as supporting cardiovascular health, aiding in athletic performance, and enhancing circulation to various organs and tissues.
L-Arginine supplements are available in various forms, including capsules, tablets, and powdered formulations, making it easy to incorporate into one's daily routine. Some products may combine L-Arginine with other nutrients or compounds to enhance its effects further.
Key potential benefits of L-Arginine supplementation include:
1:Cardiovascular Support: By promoting vasodilation and improving blood flow, L-Arginine may help maintain healthy blood pressure levels and support overall heart health.
2:Athletic Performance: Increased blood flow to muscles may aid in exercise performance and recovery, as it helps deliver essential nutrients and oxygen to the muscles during physical activity.
3:Erectile Function: L-Arginine's role in promoting blood flow has led to its use as a natural supplement for men seeking support for erectile function.
4:Immune System Support: As an amino acid, L-Arginine contributes to the synthesis of proteins necessary for a robust immune system.
5:Wound Healing: L-Arginine's involvement in collagen synthesis may help in wound healing and tissue repair.
|
Tests
|
Limits
|
Test results
|
|
Description
|
White crystals or crystalline powder
|
conforms
|
|
Identification(IR)
|
concordant with the reference spectrum
|
conforms
|
|
Assay
|
98.5～101.5%
|
99.7%
|
|
Specific rotation[a].2
|
+26.3°~+27.70
|
+27.1°
|
|
Chloride(C1)
|
≤0.05%
|
<0.05%
|
|
Sulfate(SO₄)
|
≤0.03%
|
<0.03%
|
|
Iron(Fe)
|
≤30ppm
|
<30ppm
|
|
Organic Impurities
|
individual impurity ≤0.5% total impurities≤ 2.0%
|
conforms
|
|
Loss on drying
|
≤0.50%
|
0.08%
|
|
Residue on ignition
|
≤0.30%
|
0.04%
|
|
Endotoxin
|
≤6EU/g
|
<6EU/g
|
|
Total plate count
|
≤1000cfu/g
|
conforms
|
|
Yeast and Moulds
|
≤100cfu/g
|
conforms
|
|
Conclusion: Passed test according to the
Standard of USP43.
|
|
|
Pharma Sources Insight June 2024: Globalization on the Go
